Improving Diabetic Patient Health Through Assistive-Reading Technology
Increasing Health Equity Through In-The-Moment Reading Assistance for Adults With Diabetes Served at Community Health Centers
1 other identifier
interventional
193
1 country
1
Brief Summary
Type 2 Diabetes Mellitus (T2DM) affects over 30 million Americans and requires patients to competently manage their conditions at home. However, the majority of diabetes self-management education (DSME) and aftercare print materials remain overly complicated, with excessively high reading difficulty and fall short in supporting functional readiness for self- management at home, especially for the 18% of U.S. adults unable to read beyond a second-grade level. This project will determine the feasibility of implementing assistive reading technology, designed for patients with limited print or English proficiency, that will immediately expand patient capacity to understand DSME materials, increase T2DM self- management adherence and eventually reduce, at a scale, disparate outcomes in a chronic disease. It will use a small pilot trial design of the GogyUp Reader app to use with print materials versus print materials with no app support and test effects of GogyUp on three-month follow-up measures of health literacy (primary outcome) using the Health Literacy Questionnaire subscales 9 (Understanding health information well enough to know what to do") and 2 ("Having sufficient information to manage my health"); and on three-month follow-up self-reported diabetes management (secondary outcome) using the Perceived Diabetes Self-Management Scale (PDSMS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes-mellitus-type-2
Started Apr 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2022
CompletedFirst Posted
Study publicly available on registry
April 20, 2022
CompletedStudy Start
First participant enrolled
April 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 12, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedResults Posted
Study results publicly available
January 1, 2025
CompletedJanuary 1, 2025
December 1, 2024
1.1 years
March 21, 2022
October 29, 2024
December 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Health Literacy Questionnaire Subscale 9: Understanding Health Information Well Enough to Know What to do
The first primary outcome is three-month (follow up) value of the Health Literacy Questionnaire (HLQ) subscale 9: Understanding health information well enough to know what to do The "Understanding health information" subscale is a multi-item, validated subscale of the HLQ and a continuous variable. It is a 5-item subscale, with items scored 1-5 (with higher scores being better) and then mean-aggregated. This study's main objective is to study the effect of GogyUp on health literacy (the ability to use and understand written health information) as a proximal effect of support. The Understanding health information subscale is the most direct measure; three-month follow up reflects (a) brief follow-up in a pilot trial; and (b) this outcome is very proximal to the intervention.
3 months
Health Literacy Questionnaire Subscale 2: Having Sufficient Information to Manage my Health
The other primary outcome measurement is the three-month (follow up) value of the validated Health Literacy Questionnaire Subscale 2: having sufficient information to manage my health. The "Having sufficient information" subscale is a multi-item, validated subscale of the HLQ and a continuous variable. It is a 4-item subscale, with items scored 1-4 (with higher scores being better) and then mean-aggregated. This study's main objective is to study the effect of GogyUp on health literacy (def: the ability to use and understand written health information) as a most proximal effect of in-the-moment support. As such, the Having sufficient information subscale is an additional direct measure; the three-month time frame reflects (a) a brief follow-up as part of a pilot trial; and (b) is reasonable because of the use of this proximal (to the intervention) outcome based on putative mechanisms.
3 months
Secondary Outcomes (1)
Perceived Diabetes Self-Management Scale Score
3 months
Study Arms (2)
GogyUp
EXPERIMENTALParticipants in the GogyUp arm will have the GogyUp Reader app preloaded on a cellular-enabled tablet with the same patient education documents as the Control arm. Patients will be able to use on-demand / in-the-moment assistive-reading technologies to understand any word or phrase: * Speech-to-Text * Word-by-Word Translation * Alternative Formatting * Simplified and Contextualized Definitions * No-Fail Comprehension Questions * Personalized Training in Phonemic Awareness
Control
NO INTERVENTIONParticipants in the Standard Care arm will receive the standard after-visit patient education documents the clinics current provide for type 2 diabetes education and self-management.
Interventions
Participants will have unlimited access to the assistive-reading technologies available in the GogyUp Reader app for help understanding post-visit educational documents on type 2 diabetes mellitus disease management.
Eligibility Criteria
You may qualify if:
- Provision of signed and dated informed consent form
- Males and females; Aged 18-85 years
- Documented diagnosis of type II diabetes mellitus
- Has had a visit to a clinic in the past year (April 2020-February 2021); can include a telehealth visit
- Receives patient education materials and can consent in English
You may not qualify if:
- Currently enrolled in another treatment or intervention study (at pre-screen)
- Pregnancy (because pregnancy becomes the primary condition of interest)
- Note: Access to necessary resources for participating in a technology-based intervention (i.e., computer, smartphone, internet access) will not be a criterion.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GogyUp Inclead
- University of Minnesotacollaborator
Study Sites (1)
MHealth Fairview system
Minneapolis, Minnesota, 55454, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Ned Zimmerman-Bence, Co-Founder
- Organization
- GogyUp
Study Officials
- PRINCIPAL INVESTIGATOR
Ned Zimmerman-Bence
GogyUp Inc
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 21, 2022
First Posted
April 20, 2022
Study Start
April 26, 2023
Primary Completion
June 12, 2024
Study Completion
June 30, 2024
Last Updated
January 1, 2025
Results First Posted
January 1, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Study data will be available once final report has been accepted by the National Institute for Nursing Research (the funding agency). Analytic date will remain available through the University of Minnesota's Clinical Data Repository managed by the University of Minnesota's Clinical and Translational Sciences Institute.
- Access Criteria
- Criteria include employees of federal agencies or institutions of higher learning.
Dr. Shippee (having led analyses) will submit summary results to ClinicalTrials.gov following timeline completion of the analyses concurrent with manuscript results preparation, which should be within two to three months post follow-up for final participants.